Literature review of human papillomavirus vaccine acceptability among women over 26 years

被引：62

作者：

Black, Lora L. ^{[1
,3
]}

Zimet, Gregory D. ^{[2
]}

Short, Mary B. ^{[1
,3
]}

Sturm, Lynne ^{[4
]}

Rosenthal, Susan L. ^{[1
]}

机构：

[1] Univ Texas Galveston, Dept Pediat, Med Branch, Galveston, TX 77555 USA

[2] Indiana Univ, Dept Pediat, Sect Adolescent Med, Sch Med, Indianapolis, IN 46204 USA

[3] Univ Houston Clear Lake, Dept Psychol, Houston, TX USA

[4] Indiana Univ, Dept Pediat, Riley Child Dev Ctr, Sch Med, Indianapolis, IN 46204 USA

来源：

VACCINE | 2009年 / 27卷 / 11期

关键词：

Human papillomavirus vaccine; Sexually transmitted diseases; Adult women; Acceptability; HPV VACCINATION; CERVICAL-CANCER; COST-EFFECTIVENESS; HIV IMMUNIZATION; PARTICLE VACCINE; DOUBLE-BLIND; YOUNG-WOMEN; KNOWLEDGE; ATTITUDES; INFECTION;

D O I：

10.1016/j.vaccine.2009.01.035

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Vaccines for the human papillomavirus (HPV) are currently licensed for females, ages 9 through 26 years old in the U.S., and for adult women up to 45 years in some countries such as Australia. As licensure for adult women, over 26 years, is sought in other countries, it will be important to determine the acceptability to them. We reviewed the available articles on adult opinions and acceptability of vaccinating women against HPV. Predictors of acceptability included barriers, knowledge, risk, age, and marital status. Overall, acceptability rates were high, if adequate information was given and the cost was affordable. (C) 2009 Elsevier Ltd. All rights reserved.

引用

页码：1668 / 1673

页数：6

共 40 条

[1] Women's desired information about human papillomavirus [J].

Anhang, R ;

Wright, TC ;

Smock, L ;

Goldie, SJ .

CANCER, 2004, 100 (02) :315-320

[2] Acceptability to Latino parents of sexually transmitted infection vaccination [J].

Bair, Rita M. ;

Mays, Rose M. ;

Sturm, Lynne A. ;

Perkins, Susan M. ;

Juliar, Beth E. ;

Zimet, Gregory D. .

AMBULATORY PEDIATRICS, 2008, 8 (02) :98-103

[3]

Baykal C, 2008, EUR J GYNAECOL ONCOL, V29, P76

[4]

Burchell AN., 2006, Vaccine

[5] The MMR vaccination and autism controversy in United Kingdom 1998-2005: Inevitable community outrage or a failure of risk communication? [J].

Burgess, David C. ;

Burgess, Margaret A. ;

Leask, Julie .

VACCINE, 2006, 24 (18) :3921-3928

[6] Recurrent respiratory papillomatosis [J].

Derkay, CS .

LARYNGOSCOPE, 2001, 111 (01) :57-69

[7] Genital warts among 18- to 59-year-olds in the United States, national health and nutrition examination survey, 1999-2004 [J].

Dinh, Thu-Ha ;

Sternberg, Maya ;

Dunne, Eileen F. ;

Markowitz, Lauri E. .

SEXUALLY TRANSMITTED DISEASES, 2008, 35 (04) :357-360

[8] Knowledge of cervix cancer, human papilloma virus (HPV) and HPV vaccination at the moment of introduction of the vaccine in women in Belgium [J].

Donders, Gilbert G. G. ;

Gabrovska, Maria ;

Bellen, Gert ;

van Keirsbilck, Joachim ;

van den Bosch, Thierry ;

Riphagen, Ine ;

Verjans, Marcel .

ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2008, 277 (04) :291-298

[9] HPV vaccine acceptability in a rural Southern area [J].

Fazekas, Karah I. ;

Brewer, Noel T. ;

Smith, Jennifer S. .

JOURNAL OF WOMENS HEALTH, 2008, 17 (04) :539-548

[10]

Ferris Daron G, 2007, J Low Genit Tract Dis, V11, P166, DOI 10.1097/lgt.0b013e3180324114

← 1 2 3 4 →